DRAP, Pharmaceutical Industry and HWSK Discuss Improved Access to Clotting Factors
KARACHI: Healthcare and pharmaceutical stakeholders have discussed measures to strengthen treatment and long-term care for people living with haemophilia and other bleeding di
